IGMS   $17.27  3.72% Market Closed After Close 17.23 -0.23%

IGM Biosciences Inc
Last Events:

2023-08-09 Trend pattern changed from нисходящий треугольник to симметричный треугольник.

2023-08-06 Trend pattern changed from расходящийся клин с наклоном вниз to нисходящий треугольник.

2023-08-06 Trend Power changed from medium strength to strong.

2023-08-05 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

2023-08-05 Signal in MACD changed from bullish weakening to bearish. Oscillator MACD is in the negative territory it crossed the signal line from the top and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: main and signal line crossing.

2023-08-04 Signal in Stochastic changed from bullish to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: main and signal line crossing.

2023-08-04 Signal in MACD changed from bullish to bullish weakening. Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: up-crossing the middle level.

2023-08-04 Signal in RSI changed from bullish weakening to bearish. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.


Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 9
Target Price Mean 22.89
Mean unverified/preliminary 22.89 / 22.89
Target Price Low / High 11.00 / 48.00
Median / STD DEV 24.00 / 10.96
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None None Sell
rsi Buy ActivelyBuy Sell
macd None None None
stoch None None None
ma20 Sell Sell None
ma50 ActivelyBuy None None
ma100 Sell Sell Sell
Candlestick PatternSept. 18, 2024 Dark Clouds Cover - is a candlestick pattern whereby a black candlestick opens above a white candlesticks close and below its midpoint.Considered to be a bearish reversal pattern.
ISIN US4495851085
ceo Mr. Fred M. Schwarzer J.D.
Website https://igmbio.com
IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.